Systemic Depletion of Macrophages by Liposomal Bisphosphonates Reduces Neointimal Formation Following Balloon-Injury in the Rat Carotid Artery

Journal of Cardiovascular Pharmacology

Volumn 42, Issue 5, 2003, Pages 671-679

  Danenberg, Haim D ^a   Fishbein, Ilia ^b   Epstein, Hila ^b   Waltenberger, Johannes ^c   Moerman, Evgeny ^b   Mönkkönen, Jukka ^d   Gao, Jianchuan ^b   Gathi, Irith ^b   Reichi, Reuven ^b   Golomb, Gershon ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c UNIVERSITY HOSPITAL ULM   (Germany)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Balloon injury; Bisphosphonates; Macrophages; Monocytes; Vascular repair

Indexed keywords

2 (2 AMINOPYRIMIDINO)ETHYLIDENE 1,1 BISPHOSPHONIC ACID BETAINE; ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CLODRONIC ACID; GELATINASE A; INTERLEUKIN 1BETA; ISA 13 1; LIPOSOME; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY ED 1; MONOCLONAL ANTIBODY ED 2; PAMIDRONIC ACID; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTERY WALL; ARTICLE; BALLOON; CAROTID ARTERY INJURY; CELL LINE; COMMON CAROTID ARTERY; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INTIMA; MACROPHAGE; MALE; METHODOLOGY; MICROENCAPSULATION; MOUSE; NONHUMAN; PATHOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

ANGIOPLASTY, BALLOON; ANIMALS; CAROTID ARTERY, COMMON; CELL LINE; DIPHOSPHONATES; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNOSUPPRESSION; LIPOSOMES; MACROPHAGES; MALE; MICE; RATS; TUNICA INTIMA;

EID: 10744222354     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200311000-00014     Document Type: Article

References (31)

1. Simon D, Chen Z, Seifert P, et al. Decreased neointimal formation in Mac-1-/- mice reveals a role for inflammation in vascular repair after angioplasty. J Clin Invest. 2000;105:293-300.
2. Tanaka H, Sukhova GK, Swanson SJ, et al. Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury. Circulation. 1993;88:1788-1803.
3. Hanke H, Hassenstein S, Ulmer A, et al. Accumulation of macrophages in the arterial vessel wall following experimental balloon angioplasty. Eur Heart J. 1994;15:691-698.
4. Hancock W, Adams D, Wyner L, et al. CD4+ mononuclear cells induce cytokine expression, vascular smooth muscle cell proliferation, and arterial occlusion after endothelial injury. Am J Pathol. 1994;145:1008-1014.
5. Libby P, Shcwartz D, Brogi E, et al. A cascade model for restenosis. A special case of atherosclerosis progression. Circulation. 1992;86:11147-11152.
6. Feldman L, Aguirre L, Ziol M, et al. Interleukin-10 inhibits neointimal hyperplasia after angioplasty or stent implantation in hypercholesterolemic rabbits. Circulation. 2000;101:908-916.
7. Moreno P, Bernardi V, Lopez-Cuellar J, et al. Macrophage infiltration predicts restenosis after coronary intervention in patients with unstable angina. Circulation. 1996;94:3098-3102.
8. Pietersma A, Koflard M, Wit EAd, et al. Late lumen loss after coronary angioplasty is associated with the activation status of circulating phagocytes before treatment. Circulation. 1995;91:1320-1325.
9. Danenberg H, Fishbein I, Gao J, et al. Macrophage depletion by clodronate-containing liposomes reduce neointimal hyperplasia in rats and rabbits. Circulation. 2002;106:599-605.
10. Rodan GA. Mechanisms of action of bisphosphonates. Annu Rev Pharmacol Toxicol. 1998;38:375-388.
11. Mönkkönen J, Taskinen M, Auriolal SOK, et al. Growth inhibition of macrophage-like and other cell types by liposomes-encapsulated calcium-bound and free bisphosphonates in vitro. J Drug Target. 1994;2:299-308.
12. Cohen H, Alferiev IS, Monkkonen J, et al. Synthesis and preclinical pharmacology of 2-(2-aminopyrimidinio) ethylidene-1,1-bisphosphonic acid betaine (ISA-13-1)-a novel bisphosphonate. Pharm Res. 1999;16:1399-1406.
13. Ezra A, Hoffman A, Breuer E, et al. A peptide prodrug approach for improving bisphosphonate oral absorption. J Med Chem. 2000;43:3641-3652.
14. Mönkkönen J, Heath T. The effects of liposome-encapsulated and free clodronate on the growth of macrophage-like cells in vitro: the role of calcium and iron. Calcif Tissue Int. 1993;53:139-146.
15. Golomb G, Fishbein I, Banai S, et al. Controlled delivery of a tyrphostin inhibits intimal hyperplasia in a rat carotid artery injury model. Atherosclerosis. 1996;125:171-182.
16. Fishbein I, Waltenberger J, Banai S, et al. Local delivery of platelet-derived growth factor receptor-specific tyrphostin inhibits neointimal formation in rats. Arterioscler Thromb Vasc Biol. 2000;20:667-676.
17. Banai S, Wolf Y, Golomb G, et al. Selective PDGF-receptor protein tyrosine kinase blocker attenuates smooth muscle cell outgrowth from porcine arterial tissue and human atheroma. Circulation. 1998;97:1960-1969.
18. Dijkstra CD, Dopp EA, Joling P, et al. The heterogeneity of mononuclear phagocytes in lymphoid organs: Distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology. 1984;54:589-599.
19. Majesky MW, Reidy MA, Bowen-Pope DF, et al. PDGF ligand and receptor gene expression during repair of arterial injury. J Cell Biol. 1990;111:2149-2158.
20. Waltenberger J. Modulation of growth factor action: implications for the treatment of cardiovascular diseases. Circulation. 1997;96:4083-4094.
21. Danenberg H, Welt F, Walker M, et al. Systemic inflammation induced by lipopolysaccharide increases neointimal formation following balloon and stent injury in rabbits. Circulation. 2002;105:2917-2922.
22. Serrano C, Ramires J, Venturinelli M, et al. Coronary angioplasty results in leukocyte and platelet activation with adhesion molecules expression. Evidence of inflammatory responses in coronary angioplasty. J Am Coll Cardiol. 1997;29:1276-1283.
23. Okamoto E, Couse T, De Leon H, et al. Perivascular inflammation after balloon angioplasty of porcine coronary arteries. Circulation. 2001;104:2228-2235.
24. Fishbein I, Chorny M, Rabinovich L, et al. Nanoparticulate delivery system of a tyrphostin for the treatment of restenosis. J Control Release. 2000;65:221-229.
25. Fishbein I, Chorny M, Banai S, et al. Formulation and delivery mode affect disposition and activity of tyrphostin-loaded nanoparticles in the rat carotid model. Arterioscler Thromb Vasc Biol. 2001;21:1434-1439.
26. Cohen-Sacks H, Najajreh Y, Tchaikovski V, et al. Novel PDGFbetaR antisense encapsulated in polymeric nanospheres for the treatment of restenosis. Gene Ther. 2002;9:1607-1616.
27. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999;340:115-126.
28. Ferns G, Raines E, Sprugel K, et al. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science. 1991;253:1129-1136.
29. Mintz GS, Popma JJ, Pichard AD, et al. Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation. 1996;94:35-43.
30. Hayashi S, Watanabe N, Nakazawa K, et al. Roles of P-selectin in inflammation, neointimal formation, and vascular remodeling in balloon-injured rat carotid arteries. Circulation. 2000;102:1710-1717.
31. Margolin L, Fishbein I, Banai S, et al. Metalloproteinase inhibitor attenuates neointima formation and constrictive remodeling after angioplasty in rats: augmentative effect of alpha(v)beta(3) receptor blockade. Atherosclerosis. 2002;163:269-277.